Posted:
Advanced Bionics announced an equity investment and early-stage research collaboration with Spiral Therapeutics, a clinical-stage company developing therapies for inner ear disorders. The collaboration will aim to understand whether Spiral's drug-delivery platform, which is designed for minimally invasive and targeted delivery of therapeutics to the cochlea, can be integrated into cochlear implant surgery to address unmet clinical needs.
The companies have not announced specific products or timelines. This is described as early-stage R&D exploration. Spiral Therapeutics simultaneously announced the closing of a $27 million Series B financing round to support its pipeline. All claims about potential applications are forward-looking and based on company statements.
Read their press release here.
